🇺🇸 FDA
Patent

US 10711314

Methods for diagnosing IDH-mutant cell proliferation disorders

granted A61KA61K31/015A61K31/05

Quick answer

US patent 10711314 (Methods for diagnosing IDH-mutant cell proliferation disorders) held by Agios Pharmaceuticals, Inc. expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/015, A61K31/05, A61K31/122, A61K31/194